Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 325.47B | 343.33B | 251.87B | 142.79B | 118.56B | 430.28B |
Gross Profit | 106.29B | 110.62B | 82.74B | 28.26B | 16.38B | 69.90B |
EBITDA | 21.78B | 22.37B | 11.95B | 6.95B | -36.42B | -18.32B |
Net Income | 6.90B | 8.72B | -2.62B | -9.55B | -50.05B | -25.04B |
Balance Sheet | ||||||
Total Assets | 457.89B | 412.20B | 441.35B | 414.98B | 411.45B | 414.60B |
Cash, Cash Equivalents and Short-Term Investments | 164.34B | 138.17B | 157.59B | 145.01B | 101.42B | 95.23B |
Total Debt | 245.91B | 211.86B | 266.15B | 276.75B | 277.36B | 248.56B |
Total Liabilities | 390.75B | 349.86B | 383.20B | 358.35B | 347.30B | 316.18B |
Stockholders Equity | 57.59B | 52.25B | 48.98B | 47.82B | 40.78B | 74.13B |
Cash Flow | ||||||
Free Cash Flow | 6.10B | 21.05B | 24.59B | -23.83B | -44.96B | -124.28B |
Operating Cash Flow | 6.10B | 29.25B | 31.07B | -14.91B | -28.40B | -57.72B |
Investing Cash Flow | 0.00 | 45.61B | -46.39B | 53.52B | -7.09B | -47.90B |
Financing Cash Flow | 0.00 | -55.16B | -11.79B | 5.46B | 40.71B | -5.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥178.04B | 9.44 | 3.56% | 4.28% | 47.52% | ||
73 Outperform | ¥425.82B | 25.73 | 22.21% | 1.22% | 11.92% | 33.70% | |
68 Neutral | $260.27B | 24.38 | 16.08% | 0.07% | 18.75% | 20.42% | |
67 Neutral | ¥202.89B | 15.53 | 5.27% | 3.89% | 6.96% | -21.35% | |
62 Neutral | $16.91B | 10.88 | -7.01% | 2.97% | 1.73% | -25.16% | |
59 Neutral | ¥100.41B | 11.85 | 16.85% | 1.47% | 17.20% | 44.52% | |
57 Neutral | ¥161.25B | 55.97 | ― | 77.47% | -45.82% |
H.I.S. Co., Ltd. has announced a series of measures to address and prevent the recurrence of issues related to the improper receipt of employment adjustment subsidies. The company is focusing on fostering compliance awareness, strengthening group governance, revising internal controls for subsidy applications, enhancing labor management, promoting the whistleblowing system, and improving the internal audit system. These efforts are aimed at restoring confidence and ensuring effective risk management across the group.
The most recent analyst rating on (JP:9603) stock is a Buy with a Yen2100.00 price target. To see the full list of analyst forecasts on H.I.S.Co. stock, see the JP:9603 Stock Forecast page.
H.I.S. Co., Ltd reported a 12.7% increase in net sales to 181,313 million yen for the six months ending April 30, 2025, with operating profit rising by 21.6% to 6,721 million yen. The company also announced a dividend of 10 yen per share for the fiscal year ending October 31, 2025, reflecting a positive outlook despite a decrease in comprehensive income and the exclusion of three subsidiaries from consolidation.
The most recent analyst rating on (JP:9603) stock is a Buy with a Yen2100.00 price target. To see the full list of analyst forecasts on H.I.S.Co. stock, see the JP:9603 Stock Forecast page.
H.I.S. Co., Ltd. has announced the establishment of a new subsidiary, H.I.S. SAUDI ARABIA LLC, through its consolidated subsidiary, H.I.S. Management Consulting DMCC. This move is part of the company’s strategy to expand its sales channels and create new customers in the global market, particularly in Saudi Arabia, where tourism is becoming a key industry. The impact on the company’s business performance is expected to be minor, but it positions H.I.S. to capitalize on the growing tourism sector in Saudi Arabia.
The most recent analyst rating on (JP:9603) stock is a Buy with a Yen2100.00 price target. To see the full list of analyst forecasts on H.I.S.Co. stock, see the JP:9603 Stock Forecast page.
H.I.S. Co., Ltd. announced corrections to a previous notice regarding the transfer of shares of its subsidiary, NUMBER ONE TRAVEL SHIBUYA Co., Ltd. The corrections involve financial figures related to the subsidiary’s assets and net assets per share over the past three fiscal years. This adjustment may impact stakeholders’ understanding of the subsidiary’s financial health and the strategic decisions of H.I.S. Co., Ltd.
The most recent analyst rating on (JP:9603) stock is a Buy with a Yen2100.00 price target. To see the full list of analyst forecasts on H.I.S.Co. stock, see the JP:9603 Stock Forecast page.
H.I.S. Co., Ltd. has completed the payment procedures for the disposal of its treasury stock as restricted stock compensation, involving 13,188 shares at a price of JPY 1,684 per share, totaling JPY 22,208,592. This move is part of the company’s strategy to align the interests of its directors with those of its shareholders, potentially impacting its governance and stakeholder relations positively.
The most recent analyst rating on (JP:9603) stock is a Buy with a Yen2100.00 price target. To see the full list of analyst forecasts on H.I.S.Co. stock, see the JP:9603 Stock Forecast page.
H.I.S. Co., Ltd. has decided to transfer its entire stake in its subsidiary, NUMBER ONE TRAVEL SHIBUYA Co., Ltd., as part of a strategic reorganization to enhance group governance. This move is based on the assessment that the subsidiary can sustain itself and continue its growth independently, potentially impacting the company’s operational focus and market strategy.
The most recent analyst rating on (JP:9603) stock is a Buy with a Yen2100.00 price target. To see the full list of analyst forecasts on H.I.S.Co. stock, see the JP:9603 Stock Forecast page.
H.I.S. Co., Ltd. announced that its subsidiary, Cross E Holdings Corporation Limited, has entered into a basic agreement to acquire Kyoshin Densetsu Kogyo K.K., a construction company with expertise in electrical and telecommunications work. This acquisition aims to expand Cross E’s market presence in Nagasaki Prefecture and create synergies within the group, enhancing its business operations and risk management capabilities.
The most recent analyst rating on (JP:9603) stock is a Buy with a Yen2100.00 price target. To see the full list of analyst forecasts on H.I.S.Co. stock, see the JP:9603 Stock Forecast page.
H.I.S. Co., Ltd. has announced the disposal of 13,188 treasury shares as restricted stock compensation to its directors, aligning with its plan to incentivize directors to boost corporate value and shareholder alignment. The shares, valued at JPY 22,208,592, will be subject to a 30-year transfer restriction period, ensuring long-term commitment from the directors.
H.I.S. Co., Ltd. announced disciplinary actions against officers of its subsidiaries following an investigation revealing improper receipt of employment adjustment subsidies. The company has taken steps to address management responsibility, including the resignation of a subsidiary president and compensation reductions for involved officers, reflecting its commitment to ethical governance and compliance.
H.I.S. Co., Ltd. announced changes to its governance system, establishing a Subsidiary Governance Review Committee to address issues related to subsidies and strengthen group governance. This committee, chaired by an outside director, will work alongside the Risk Management and Compliance Committee, which has been repositioned to provide broader advisory support, ensuring effective governance and compliance across the company.